Atrial Fibrillation Ablation
- Home
- Atrial Fibrillation Ablation
Treatment at the Source: Cryoablation, 3D RF Ablation, and PFA
What Is Ablation? Why Is It So Important?
While medications can alleviate symptoms and control heart rate in the treatment of atrial fibrillation, they do not eliminate AF at its source. Thanks to revolutionary developments in the field of electrophysiology over the past two decades, catheter ablation methods that directly target the areas triggering AF and offer lasting results have now become an indispensable part of daily practice.
Etymologically, the word ablation stems from Latin, meaning “removal.” In cardiology, ablation is the procedure of permanently rendering dysfunctional specific tissue areas inside the heart that produce or transmit abnormal electrical signals, using various energy sources. The primary goal of AF ablation is to eliminate the trigger signals originating mostly from the point where the blood vessels bringing blood from the lungs to the heart—the pulmonary veins—meet the left atrium. This procedure is called pulmonary vein isolation (PVI).
Today, there are three main methods used to achieve this goal: Cryoablation, three-dimensional radiofrequency ablation, and pulsed field ablation (PFA). Each has its own unique technology, advantages, and suitable patient profile.
What Is Done Before Ablation?
Regardless of the method chosen, a comprehensive preparation process is required prior to the ablation procedure.
Before the procedure, transesophageal echocardiography or cardiac CT angiography is used to confirm the absence of a blood clot in the left atrium. The anatomy of the pulmonary veins and the dimensions of the left atrium are evaluated in detail. It is confirmed that anticoagulant therapy has been used regularly; because minimizing the risk of clots before ablation is of vital importance. On the day of the procedure, the patient is placed under sedoanalgesia or general anesthesia. Thin catheters are advanced into the heart from the veins in the groin region, and access from the right atrium to the left atrium is achieved through a procedure called transseptal puncture—via a thin crossing in the partition wall of the heart. From this point on, the methods begin to diverge.
Cryoablation — Healing with Cold
How Does the Technology Work?
Cryoablation is a method that destroys target tissue using extreme cold energy instead of heat. For this purpose, liquid nitrogen oxide gas is sent into a special balloon catheter—a cryoballoon. When the balloon is inflated, its tip cools down between minus 40 and minus 60 degrees Celsius. This freezing process permanently disables the tissue at the mouth of the pulmonary vein and prevents electrical signals from passing through this pathway.
How Is the Procedure Performed?
Following the transseptal crossing, the cryoballoon catheter is advanced into the left atrium. The balloon is placed at the mouth of the pulmonary vein and inflated to completely seal this opening. Cooling then begins. This process takes about 3 to 4 minutes for each pulmonary vein. Once successful isolation is achieved, the balloon is deflated and the next vein is approached. When all four pulmonary veins are isolated, the procedure is complete.
What Are Its Advantages?
The most important feature of the cryoballoon is that it is a technically standard and reproducible method. Because the balloon sits directly at the mouth of the pulmonary vein, a wide and homogeneous ablation line is created. The procedure duration is generally shorter compared to other methods. The learning curve of the technology is relatively easier. It offers excellent results, especially in patients with paroxysmal, meaning episodic, AF.
What Are Its Limitations?
The most significant limitation of the cryoballoon is that the balloon does not fit every anatomy perfectly. Technical difficulties may occur in pulmonary veins with abnormal anatomy—such as more than four veins or common vein variations. In addition, the balloon alone may not be sufficient in complex or long-standing AF cases that require additional ablation outside of the pulmonary veins. Phrenic nerve injury is a rare but known complication of the procedure.
What Are the Success Rates?
Large-scale clinical studies show that the cryoballoon achieves a 70 to 80 percent success rate after a single procedure in paroxysmal AF. When a second procedure is included, this rate rises above 85 percent.
Three-Dimensional (3D) Radiofrequency Ablation — The Pinnacle of Precision
How Does the Technology Work?
Radiofrequency ablation is based on the principle of converting high-frequency electrical current into heat within the tissue. By generating a controlled heat between 50 and 60 degrees Celsius at the catheter tip, the target tissue is destroyed in a point-by-point manner. Three-dimensional mapping systems—such as platforms like CARTO, EnSite, or Rhythmia—create the electrical and anatomical map of the heart in real time, showing with millimeter precision where the catheter is, which points have been ablated, and which areas are not yet completed.
How Is the Procedure Performed?
Following the transseptal crossing, mapping catheters are systematically moved within the left atrium to create a three-dimensional anatomical map of the left atrium and pulmonary veins. Pulmonary vein ostia are marked on this map. Then, ablation catheters perform point-by-point ablations around these ostia to create a continuous isolation line. Contact force, impedance, and temperature are monitored in real time at each point. When the procedure is complete, the created line prevents all electrical signals originating from the pulmonary veins from passing into the left atrium.
Contact force technology
is an important component of this method. This system, which measures the contact pressure of the catheter with the tissue down to the gram, ensures that sufficiently deep ablation is performed while preventing the application of excessive energy.
What Are Its Advantages?
The greatest strength of three-dimensional radiofrequency ablation is its flexibility and customizability. It is not limited to pulmonary vein isolation alone; in complex AF cases, additional ablation lines, scar tissue areas, and other triggering points can also be mapped and treated. Anatomical variations do not pose a problem because an individual map is created for each patient. Long-standing persistent AF, previously unsuccessful ablation attempts, and cases accompanied by structural heart disease are among the situations where this method is specifically preferred. The use of X-rays is significantly reduced thanks to the mapping system.
What Are Its Limitations?
Radiofrequency ablation is a method that requires greater experience and technical skill. The procedure duration may be longer compared to cryoablation. Since heat-based energy is used, the patient may feel mild discomfort during the procedure; therefore, deep sedation or general anesthesia is frequently preferred. Atrioesophageal fistula—an abnormal connection between the esophagus and the left atrium—is an extremely rare but serious complication; the esophagus is constantly kept under monitoring to minimize this risk.
What Are the Success Rates?
Single-procedure success in paroxysmal AF is reported between 75 and 85 percent. In persistent AF, success rates span a wide range and vary between 60 and 80 percent with additional ablation strategies. When repeated procedures are included, long-term success increases even further.
PFA — Pulsed Field Ablation: Next-Generation Technology
Why Is This Method Revolutionary?
Pulsed Field Ablation (PFA) is the most exciting development in the world of AF ablation in recent years. Using short-term, high-voltage electrical pulses instead of heat or cold to irreversibly destroy cell membranes, this method has opened a completely new chapter in cardiac ablation.
How Does the Technology Work?
The basic principle of PFA is a biophysical phenomenon called irreversible electroporation. The applied electrical pulses create permanent pores in the cell membrane and trigger cell death. However, the most striking feature of this effect is this: different tissue types show different sensitivities to these electrical pulses. While heart muscle cells are extremely sensitive to this type of energy, neighboring structures such as the esophagus, phrenic nerve, and pulmonary veins are much more resistant.
This selective effect is the fundamental feature that radically distinguishes PFA from other methods.
How Is the Procedure Performed?
Today, the PFA procedure is performed by placing specially designed flower-shaped or basket-structured catheters into the left atrium. The arms of these special catheters, also known as penta-spline or flower catheters, are placed at the mouth of the pulmonary vein. Then, very short-term—ranging from microseconds to milliseconds—high-voltage electrical pulses are applied. The procedure is completed extremely quickly for each pulmonary vein. All isolation can be performed in just a few minutes.
What Are Its Advantages?
The most important advantage of PFA is its superior safety profile regarding neighboring structures. The risks of esophageal injury and phrenic nerve injury, which always exist in heat-based methods, are dramatically reduced with PFA. Thanks to this selective effect, more aggressive and confident ablation can be performed.
The procedure is extremely fast. In experienced hands, total pulmonary vein isolation can be completed in a very short time. It also offers a positive profile in terms of patient comfort.
Another important feature of PFA is the permanence of ablation lesions. Early studies indicate that lesions created with PFA are more homogeneous and more permanent compared to heat-based methods. Pulmonary vein reconnection—the previously isolated vein regaining conductivity after ablation—is observed less frequently compared to other methods.
Integrating with three-dimensional mapping systems, PFA catheters offer the opportunity for both anatomical mapping and ablation in the same session.
Limitations and Unknowns
PFA is a relatively new technology, and long-term data is not yet as extensive as that of radiofrequency ablation. Nonetheless, the initial studies published are extremely promising. In some patients, temporary atrial fibrillation or rhythm changes may be observed during PFA. The technology is developing rapidly; research on new catheter designs and energy protocols is ongoing.
What Are the Success Rates?
Published early studies show single-procedure success of PFA in paroxysmal AF between 75 and 85 percent. These rates are comparable to radiofrequency ablation; however, PFA achieves them in a much shorter time and with a much safer profile. Long-term results in persistent AF are still under investigation.
Which Method Suits Whom?
The answer to this question actually depends on two main elements rather than the method itself: the experience of the physician and the individual profile of the patient.
As of today, the success rates of cryoablation, three-dimensional radiofrequency ablation, and PFA are quite close to each other. Large-scale comparative studies reveal that when correct patient selection is made and when applied in experienced hands, all three methods offer similar efficacy and safety profiles. Therefore, there is no universal answer to the question “which method is better?”
What truly matters is this: which method best adapts to that patient, that anatomy, and the expertise of that center?
The method that a center has focused on for years and mastered in thousands of cases is the right method for that center. Technical knowledge and manual dexterity are acquired over time; mature experience directly determines success. Therefore, the best result for the patient is brought not by the newest technology, but by the physician who uses that technology best.
On the patient side, individual evaluation supersedes everything. The type and duration of AF, the size and function of the left atrium, pulmonary vein anatomy, accompanying heart diseases, previous ablation attempts, and the patient’s general health status—all these factors shape the method selection. Two patients carrying the same diagnosis can achieve the best results from different approaches due to their distinct clinical profiles.
In many advanced electrophysiology centers, these three methods are used not as competitors, but as complementary tools. When necessary, applying different methods together in the same session is also possible.
In conclusion, the best ablation method is the one individually determined by the electrophysiologist who best understands the patient’s needs, transparently communicates the options, and possesses real experience in implementation.
What to Expect After Ablation?
Following the procedure, the patient is monitored for a few hours in the cardiology intensive care unit or a special monitoring unit. Most patients are discharged the next day or within two days. In the first weeks after the procedure, some patients may experience palpitations; this is mostly a temporary process called the “blanking period” and does not mean permanent failure. For this reason, the first three months after ablation are excluded from evaluation.
It is recommended to continue anticoagulant therapy for at least two to three months; in some patients, it may be necessary to continue for a longer period depending on the risk profile. The success of the ablation is monitored through regular cardiology follow-ups, Holter monitoring, and echocardiography.
Ablation is a “reset” procedure. Adhering to healthy lifestyle changes after the procedure—such as weight control, treatment of sleep apnea, alcohol restriction, and blood pressure management—directly affects success.
What Are the Risks of Ablation?
As with any interventional cardiology procedure, AF ablation also carries certain risks. However, in experienced hands and using modern technology, these risks are kept extremely low.
Vascular access complications in the groin region can be seen, albeit rarely. Pericardial effusion—fluid accumulation between the heart sac and the heart—is a known but rare complication in all methods. Although the risk of stroke and transient ischemic attack is extremely low, anticoagulation is meticulously maintained during the procedure for this reason. Esophageal injury, which is specific to heat-based methods, has been significantly reduced with PFA. Phrenic nerve injury is a known but mostly temporary complication, especially in cryoablation. Pulmonary vein stenosis is a problem encountered with early-period techniques and largely overcome with modern methods.
Conclusion: A New Era in AF Ablation
Atrial fibrillation ablation is one of the fastest-growing and most exciting fields in cardiology. When the standardization brought by cryoablation, the precision provided by three-dimensional radiofrequency ablation, and the safety revolution offered by PFA come together, patients with AF can today be offered treatment options that were unimaginable twenty years ago.
The important thing is that each patient is evaluated individually, the right method is applied at the right time, and a comprehensive follow-up program is maintained after the procedure. AF ablation is not a miracle; but in the right hands and under the right conditions, it is a powerful tool that radically changes the quality of life and aims to treat AF at its source.
This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.